Wilms Tumor clinical trials

Explore recruiting wilms tumor clinical trials.

Recruiting wilms tumor studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Wilms Tumor trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

First-in-human interleukin-15-transpresenting Wilms’ tumor protein 1-targeting autologous dendritic cell vaccination in cancer patients

Belgium

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

MetroWILMS-1906: Phase 1-2 trial evaluating metronomic chemotherapy in patients with relapsed or refractory Wilms tumor

France

Therapeutic exploratory (Phase II) EU CTIS Study details

Wilms’ tumor (WT1) antigen-targeted dendritic cell vaccination to prevent relapse in adult patients with acute myeloid leukemia: a multicenter randomized phase II trial

Belgium

Therapeutic exploratory (Phase II) EU CTIS Study details

First-line immunotherapy using Wilms’ tumor protein 1 (WT1)-targeted dendritic cell vaccinations for malignant pleural mesothelioma

Belgium

Therapeutic exploratory (Phase II) EU CTIS Study details

Adjuvant dendritic-cell immunotherapy plus temozolomide following surgery and chemoradiation in patients with newly diagnosed glioblastoma

Belgium

Therapeutic exploratory (Phase II) EU CTIS Study details

LIGHTBEAM-U01 Substudy 01D: A Phase 1b/2 Substudy to Evaluate the Safety and Efficacy of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors

France, Spain, Sweden, Germany, Italy, Belgium +1 more

Phase I and Phase II (Integrated)- Other EU CTIS Study details

Wilms Tumor trials by city

Wilms Tumor in Toronto Wilms Tumor in Vancouver Wilms Tumor in Montreal Wilms Tumor in Calgary Wilms Tumor in Edmonton Wilms Tumor in Ottawa Wilms Tumor in Winnipeg Wilms Tumor in Quebec City Wilms Tumor in Hamilton Wilms Tumor in Kitchener Wilms Tumor in London Wilms Tumor in Halifax Wilms Tumor in New York Wilms Tumor in Los Angeles Wilms Tumor in Chicago Wilms Tumor in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease